PubMedJuly 17, 2026
Chronic Infections: A Hidden Catalyst of Cardiac Aging
by Walsh Noah
Chronic infections can accelerate cardiac aging by inducing inflammation and cellular senescence, highlighting the need for anti-infective strategies in cardiovascular health.
Key Findings
- 1Chronic infections can induce aging phenotypes in the heart, leading to premature cardiac decline.
- 2Persistent inflammation from chronic infections mirrors the sterile inflammation associated with natural aging.
- 3Dysregulation of mTOR signaling due to chronic infection triggers cardiomyocyte senescence.
- 4Chronic infections can accelerate left ventricular hypertrophy and myocardial remodeling.
- 5Monitoring hsCRP levels can help assess chronic inflammation linked to cardiac aging.
Cardiovascular diseases are the leading cause of death globally, with aging being the most significant risk factor. Recent research indicates that chronic infections may act as catalysts for cardiac decline, inducing aging phenotypes prematurely. Pathogens such as viruses, bacteria, and parasites can evade the immune system, leading to a state of 'inflammaging'βa chronic, low-grade inflammation characterized by persistent cytokine signaling and leukocyte infiltration. This inflammatory environment mirrors the sterile inflammation associated with natural aging.
Mechanistically, chronic infections disrupt the heart's homeostatic pathways, triggering cardiomyocyte senescence through dysregulation of mTOR signaling and impairment of autophagy. This process leads to mitochondrial dysfunction and increased production of reactive oxygen species (ROS), which can cause oxidative DNA damage and metabolic exhaustion in the myocardium. Furthermore, chronic infections can accelerate structural changes in the heart, such as left ventricular hypertrophy and myocardial remodeling, through immune subversion and autoimmunity.
For individuals, understanding the link between chronic infections and cardiac aging is crucial. By prioritizing anti-infective strategies, individuals can potentially mitigate the risks associated with cardiovascular diseases. This includes maintaining a healthy lifestyle, managing stress, and ensuring vaccinations are up to date to prevent infections that could lead to chronic inflammation.
In terms of biomarkers, this research connects to several key indicators of metabolic health. For instance, elevated levels of hsCRP (high-sensitivity C-reactive protein) can indicate chronic inflammation, while mitochondrial dysfunction may correlate with elevated triglycerides and altered lipid metabolism. Monitoring these biomarkers can provide insights into oneβs cardiovascular health and the potential impact of chronic infections.
In conclusion, recognizing chronic infections as a modifiable risk factor for cardiac aging emphasizes the importance of preventive health measures. Individuals should be proactive in their health management to reduce the risk of infections and associated cardiovascular decline.
Related Biomarkers
HSCRPALTGGT
Calculate & Evaluate on Metabolicum
Original Source
DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.